Skip to main content

Table 1 Baseline characteristics of the three treatment groups.

From: Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)

 

Olanzapine

Risperidone

Haloperidol

 
 

N = 2128

N = 417

N = 112

p-value

Age (years)

35.6 ± 11.7

34.4 ± 11.2

34.3 ± 10.4

NS

Sex (% females)

36.3

34.1

39.3

NS

Disease Duration (years)

11.1 ± 9.6

10.3 ± 9.0

9.5 ± 9.5

NS

Schizophrenia subtype

    

(%)

    

Paranoid

64.7

65.1

72.3

 

Undifferentiated

13.6

13.7

11.6

 

Residual

12.8

11.8

5.4

NS

Disorganized

8.4

8.4

10.7

 

Catatonic

0.5

1.0

0.0

 

Baseline CGI-S

4.66 ± 0.91,2

4.53 ± 0.9

4.9 ± 0.91

1 p < 0.005 (RIS)

    

2 p < 0.050 (HAL)

Baseline GAF

44.9 ± 14.83,4

46.7 ± 14.6

40.7 ± 16.2

3 p < 0.050 (RIS)

    

4 p <0.005 (HAL)